Nurix Therapeutics (NRIX) Treasury Shares (2019 - 2026)

Nurix Therapeutics (NRIX) has 8 years of Treasury Shares data on file, last reported at $3.1 million in Q2 2026.

• On a quarterly basis, Treasury Shares rose 3.13% year-over-year to $3.1 million in Q2 2026; TTM through May 2026 was $3.1 million, a 3.13% increase from a year earlier, with the FY2025 full-year figure at $2.2 million, up 14.82% from the prior year.
• Treasury Shares for Q2 2026 stood at $3.1 million, down from $3.4 million in the prior quarter.
• Over the last five years, Treasury Shares for NRIX reached as high as $3.4 million in Q1 2026 and fell as low as $649382.0 in Q1 2022.
• Historically, Treasury Shares has averaged $1.9 million across 5 years, with a median of $2.0 million in 2024.
• Across the five-year window, Treasury Shares jumped 3824.12% in 2022 and rose 3.13% in 2026, its largest moves.
• Year by year, Treasury Shares stood at $784824.0 in 2022, then surged by 58.77% to $1.2 million in 2023, then jumped by 56.98% to $2.0 million in 2024, then gained by 14.82% to $2.2 million in 2025, then soared by 36.69% to $3.1 million in 2026.
• Per Business Quant data, the three most recent Treasury Shares figures were $3.1 million in Q2 2026, $3.4 million in Q1 2026, and $2.2 million in Q4 2025.